A lot of global products are yet to be launched in the country. In the last eight months, we have launched six products from our global product portfolio.
Merck is all set to introduce three of its money-spinning drugs - Cosopt, Invanz and Pneuvax in India.
In spite of all their complaints, pharma MNCs have been gaining market share in India. And this growth has come largely with generics.
Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with Indian drug firms Sun Pharma, Cipla, Dr Reddy's, Emcure Pharma and Hetero Labs, its Indian arm said on Tuesday.
The company did not respond to specific queries on the project's expansion.